Electrochemical dynamics of cytochrome p450-3a4 isoenzyme biosensor for protease inhibitor antiretroviral drug

Electrochemical dynamics of cytochrome p450-3a4 isoenzyme biosensor for protease inhibitor antiretroviral drug

Show other versions (2)

<p>The highly active antiretroviral therapy (HAART) drug agent, indinavir, and the endocrine disruptor compound, 2,4-dichlorophenol (2,4-DCP), are directly related to two of South Africa&rsquo === s, and in fact, two of the globe&rsquo === s most fundamentally important and comprehensi...

Full description

Bibliographic Details
Main Author:	Hendricks, Nicolette Rebecca
Format:	Others
Language:	English
Published:	2010
Subjects:	Antiretroviral therapy
Online Access:	http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_3467_1361368134

Similar Items

Electrochemical dynamics of cytochrome p450-3a4 isoenzyme biosensor for protease inhibitor antiretroviral drug
by: Hendricks, Nicolette Rebecca
Published: (2010)

Electrochemical dynamics of cytochrome P450-3A4 isoenzyme biosensor for protease inhibitor antiretroviral drug
by: Hendricks, Nicolette Rebecca
Published: (2014)

The Place of protease inhibitors in antiretroviral treatment
by: S.B. Tenore, et al.

Safety of antiretroviral drugs
by: Anđelković Milena, et al.
Published: (2016-01-01)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
by: Ruxandra-Cristina Marin, et al.
Published: (2021-03-01)

Drug-drug interactions between antiretrovirals and bedaquiline
by: Pandie, Mishal
Published: (2018)

Electrochemical cytochrome P450 enzymatic biosensors for the determination of the reactivity of TB drugs
by: Rassie, Candice
Published: (2020)

Antiretroviral activity of protease inhibitors against Toxoplasma gondii
by: Lianet Monzote, et al.
Published: (2013-02-01)

Antiretroviral activity of protease inhibitors against Toxoplasma gondii Terapia antiretroviral de inibidores da protease contra Toxoplasma gondii
by: Lianet Monzote, et al.
Published: (2013-02-01)

The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
by: Sychev DA, et al.
Published: (2018-05-01)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015-03-01)

High incidence of adverse reactions to initial antiretroviral therapy in Brazil
by: C.A. Menezes de Pádua, et al.
Published: (2006-04-01)

The investigation of genotypic antiretroviral drug resistance in the context of the South African national antiretroviral roll-out programme
by: Van Zyl, Gert Uves
Published: (2012)

Cutting the cost of South African antiretroviral therapy using newer, safer drugs
by: W F Venter, et al.
Published: (2017-01-01)

Reasons for disclosure and non-disclosure of HIV diagnosis to children on antiretroviral therapy at the paediatric clinic, Odi Hospital
by: Mahloko, Johanna Metja
Published: (2013)

Factors associated with poor adherence amongst patients receiving antiretroviral therapy at the intermediate hospital Oshakati in Namibia
by: Bauleth, Maria Francineth
Published: (2011)

Factors associated with poor adherence amongst patients receiving antiretroviral therapy at the intermediate hospital Oshakati in Namibia
by: Bauleth, Maria Francineth
Published: (2011)

Electrochemical dynamics of cytochrome P450 (2D6) biosensors for selective serotonin re-uptake inhibitors (SSRIs)
by: Ngece, Rachel Fanelwa.
Published: (2007)

Electrochemical dynamics of cytochrome P450 (2D6) biosensors for selective serotonin re-uptake inhibitors (SSRIs)
by: Ngece, Rachel Fanelwa.
Published: (2007)

Electrochemical dynamics of cytochrome P450 (2D6) biosensors for selective serotonin re-uptake inhibitors (SSRIs)
by: Ngece, Rachel Fanelwa
Published: (2013)

HIV-1 drug resistance genotypic profiles in children with undetectable plasma viremia during antiretroviral therapy
by: Daniela Souza Araújo de Angelis, et al.

Glycyrrhetinic acid might increase the nephrotoxicity of bakuchiol by inhibiting cytochrome P450 isoenzymes
by: Aifang Li, et al.
Published: (2016-11-01)

The Effect of Vinpocetine on Human Cytochrome P450 Isoenzymes by Using a Cocktail Method
by: Lingti Kong, et al.
Published: (2016-01-01)

Risk-factors for non-adherence to antiretroviral therapy Fatores preditivos de não-adesão à terapia antiretroviral
by: Márcia Cristina Fraga Silva, et al.
Published: (2009-06-01)

Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data
by: Ashley O. Otto, et al.
Published: (2021-05-01)

A hyperkeratotic drug reaction in a patient on antiretroviral therapy
by: Kayla H. Felix, MS, et al.
Published: (2020-12-01)

Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda
by: Edwin Nuwagira, et al.
Published: (2021-03-01)

COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)

Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)

Activity of antiretroviral drugs in human infections by opportunistic agents
by: Izabel Galhardo Demarchi, et al.
Published: (2012-03-01)

Retention of HIV positive person at antiretroviral therapy clinics in post-conflict Northern Uganda
by: Ocero, Andrew Alyao
Published: (2010)

Avances recientes en VIH/SIDA: Terapia antiretroviral.
by: Ernesto Scerpella, et al.
Published: (1997-01-01)

Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy
by: Rocio Jiménez-Galán, et al.
Published: (2016-07-01)

Barriers to adherence to antiretroviral treatment among adolescents in Onandjokwe district, Namibia
by: Eliphas, Hatutale John
Published: (2017)

Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women
by: Nidhi Chauhan, et al.
Published: (2021-01-01)

Restoration of cellular immunity in HIV-infected individuals on antiretroviral therapy
by: Fatime Ramla, Tanko
Published: (2017)

Psychosocial and Personal Level Circumstances Associated with Antiretroviral Therapy Non-adherence among HIV Positive Antiretroviral Therapy User Clients in Debre Birhan Referral Hospital
by: Dinaol Urgessa Gita, et al.
Published: (2019-11-01)

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
by: Reynolds Steven J, et al.
Published: (2012-12-01)

Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia
by: Tucho WA, et al.
Published: (2021-06-01)

Current antiretroviral drugs for human immunodeficiency virus infection: review article
by: Ahmad Tavakoli, et al.
Published: (2019-08-01)